Translational Medicine
Open Access

A Randomised Review on Nanotechnology and Nanosuspensions

Munnuri Ajay kumar^{* *}Correspondence: Munnuri Ajay kumar, Department of Pharmacy, Bhaskar Pharmacy college, India, Tel: 9356847596, Email:

Author info »

Nanotechnology is the science and innovation at the nanoscale, which is around 1 to 100 nanometers and it can be utilized over the complete range of logical areas counting life sciences and healthcare [1]. Nanomedicine is one of the foremost seriously zones of inquire about in nanotechnology and is connected broadly for the anticipation, conclusion and treatment of illnesses. It is utilized in pharmaceutical sciences with the destinations of diminishing poisonous quality and minimizing side impacts of drugs by focusing on them to the particular location of activity, diminishing their dosage through moved forward bioavailability; lessening dosing recurrence by controlling medicate discharge into the human body; and moving forward rack life by upgrading their soundness.

This eventually contributes to expanded security, viability, quiet compliance, and expanded rack life of sedate and at last decreased healthcare costs [2-4]. There are numerous pushed ranges where medicate conveyance frameworks can be created utilizing nanotechnology. such as, terminal arrangements, transdermal sedate conveyance frameworks (TDDS) especially for cancer, upgraded bioavailability through progressed disintegration and retention and more.

A pharmaceutical nanosuspension may be a biphasic fluid framework in which insoluble strong sedate particles of submicron extend are consistently scattered in an watery vehicle. The dose shapes are colloidal in nature and more often than not stabilized utilizing surfactants and polymers, and implied to be managed through different courses such as verbal, parenteral, topical, nasal, ocular and more [5]. Nanosuspension could be a innovative instrument connected primarily to disentangle the issue of destitute solvency and bioavailability of drugs and once in a while to move forward medicate security and adequacy by modifying their pharmacokinetics.

It is utilized as an elective approach to lipid frameworks, when the sedate is insoluble in both, watery and natural media.

The diminished molecule measure of ineffectively water-soluble medicate to nano run, hugely increments surface zone driving to expanded rate of disintegration or an increment in immersion solvency due to an expanded disintegration weight.

Technologies for preparing nanosuspension

Two approaches are for the most part connected in planning nanosuspension. Bottom-up approach- It is based on the guideline of to begin with dissolving the medicate atoms in a dissolvable and after that building them up to nanosized particles. Beat- down approach-This is based on the rule of breaking down huge medicate particles to littler particles that are in nano extend.

Bottom–up approach

Nano Precipitation

This procedure is an headway of coprecipitation strategy of making suspensions [6]. It includes dissolving the medicate in a dissolvable and after that accelerating the broken up medicate particles from the dissolvable which advance develop up to nanoparticles. Thus this prepare takes put in two steps specifically, nucleation and gem development. Care must be taken to control gem development at nano level.

Precipitation by Liquid Solvent anti solvent Addition

This strategy utilizes including an antisolvent to the medicate arrangement which is miscible with the dissolvable in which medicate is broken down [7, 8]. The anti-solvent is included in lean stream beneath ceaseless blending or sonication. This makes a gigantic amount of cores of supersaturated sedate which at long last develop to nanosize. It is of most extreme significance to control the measure of particles and avoid atomic affiliation and encourage precious stone development. This could be accomplished by using stabilizers. Components that administer the required molecule measure incorporate concentration of medicate arrangement utilized, the sort of nonsolvent, tumult or sonication speed and choice of reasonable stabilizers.

Precipitation in Presence of Supercritical Fluid

The foremost common supercritical liquid is CO2 and the procedure included is known as supercritical antisolvent precipitation (SAS). This includes bringing the sedate arrangement in contact with a supercritical liquid which in turn leads to immersion of the fluid dissolvable and thus precipitation of solute due to hostile to dissolvable impact [9].

Precipitation by Removal of Solvent

Here the medicate is to begin with broken up in an natural dissolvable. This dissolvable is at that point evacuated by dissipation, either by lessening the weight or by ceaseless mixing [10].

a) Precipitation in Presence of High Energy Processes

This strategy is appropriate for expansive scale generation and utilizes procedures such as shower drying or solidify drying to deliver nanocrystals [11].

Top- down approach

This approach finds application through multiple technologies mentioned as following:

High-pressure Homogenization

This methodology employs Microfluidizer [12] to produce nanosuspension which works on anyone of the following principles:

Jet Stream

Here two turbulent fly streams of fluid suspension are passed through a homogenization chamber, where these streams encroach on each other and on chamber divider [13]. The molecule measure decrease comes about due to tall shear powers, molecule collision and cavitation strengths. The nanosuspensions delivered by this strategy are for the most part polydisperse in nature and the molecule measure dispersion depends on test parameters such as number of cycles, weight and speed of the fluid streams

Piston-gap

In this strategy a fluid scattering of the dynamic rule containing stabilizer/surfactant is compressed to a weight extending from 100 to 2000 bar and extended through a homogenization valve comprising of a valve cylinder, an affect ring and a valve situate [14, 15]. The vitality era which is contributed by inter-particle impacts, collision between the particles and the valve piston/impact ring and the vitality produced by cavitation and turbulence, leads to molecule estimate decrease in nano extend This innovation was created by R. H. Müller and is portrayed in
U.S. Pat. No. 5,858,410, EP 1964605 and is named as “Dissocubes”.

Water Reduced or Non Aqueous Media

This innovation is named as Nanopure™ [16] and is utilized for making nanosuspensions in non watery media such as oil or PEG or water decreases media such as glycerol-water or ethanol water blends at moo temperatures. Here comminution comes about due to shear strengths, molecule collision and turbulence but no cavitation. This strategy is especially valuable for temperature delicate drugs and for creating nanosuspension in non watery media.

2. Media Milling Technique

Typically one of the foremost conventional approaches for molecule estimate decrease. This innovation was protected for making nanosuspensions by applying acoustic vitality to break the dynamic pharmaceutical compound to the desired estimate extend [17]. It includes the utilization of media which is really dots or pearls of different sizes, densities, and fabric. Most commonly utilized globules are of zirconium, stainless steel, glass or profoundly cross-linked polystyrene tar [18]. The pearls are moved by a stirrer, the sedate is ground to nanocrystals in between the pearls. The procedure utilizes shearing and affect powers (in conjunction with the process) to diminish the estimate of the molecule. Usually the fundamental innovation created by G. Liver sidge and co-workers and these days used by the company Nanosystems® (by and by claimed by élan). But this procedure features a drawback of disintegration of process and chances of defilement of item.

3. Combination Techniques

The innovation is planned to empower water insoluble drugs to gotten to be solutions. It combines the micro precipitation and tall weight homogenization procedure and effectively overcomes downsides of both [19]. Beginning step is micro precipitation by solvent-anti solvent strategy, which includes expansion of anti solvent to a medicate arrangement containing stabilizers to induce accelerates in smaller scale extend which are at that point put to communition by subjecting the slurry to tall weight homogenization. This produces molecule in nano run with moved forward thermodynamics as this step works out a check on precious stone development of nanoparticles.

Applications of nano biphasic dosage forms in drug delivery systems

Nanosuspensions

Oral Drug Delivery

Nano suspensions are arranged primarily with a see to improve bioavailability of ineffectively solvent drugs by improving their solvency. As of now this approach has been utilized by numerous analysts for making strides bioavailability of drugs through verbal course. Non nucleoside switch transcriptase inhibitors (NNRTIs) are a particular lesson of against helps drugs and their utilize was restricted owing to moo bioavailability coming about from destitute disintegration [20]. “Nevirapine, a BCS course II NNRTI with undesirable solvency and disintegration energy from the measurement shape was defined as nanosuspension by nanoedge strategy which expanded its solvency a few times as too chemical stability” [21]. So also, nanocrystalline suspension of ineffectively dissolvable medicate itraconazole arranged by pearl processing strategy was found to be promising for verbal sedate conveyance for treatment of contagious disease [22]. Moreover, drugs such as efavirenz [23] and furosemide [24] were defined as nanosuspension for moved forward verbal bioavailability.

Parenteral Drug Delivery

The key reason to define parenteral nano suspension is either focusing on the sedate to particular location or dragging out its activity. Etoposide-loaded bovine serum egg whites (BSA) nanosuspension was defined for parenteral conveyance with an objective of focusing on conveyance to lung; diminish poisonous quality, and side impacts of etoposide [25].

Ocular Drug Delivery

These are created to dodge quick precorneal disposal and seepage by gravity and for improving the saturation of sedate through cornea and diminish the recurrence of organization by defining controlled discharge dose shapes [26]. Itraconazole- loaded chitosan nanosuspension were arranged and assessed and were found to appear essentially higher rate total saturation for visual conveyance as compared to suspensions accessible within the advertise [27]. Pilocarpine stacked eudragit nanosuspension was defined with point to move forward the accessibility of medicate at intraocular level and to diminish the recurrence of medicate organization [28].

Pulmonary Drug Delivery

Nanosuspensions for pneumonic sedate conveyance are defined with a see to focusing on the sedate to lungs. Fluticasone nanosuspension for airborne conveyance had been explored as effective detailing for intranasal (IN) dosing and was found to be proficient for focusing on drugs to lungs [29]. So also, fluticasone and budesonide nanosuspensions that were arranged for pneumonic conveyance moreover appeared profound lung testimony and quick lung assimilation [30].

Conclusion Nanotechnology has gained its place in mainframe drug delivery system particularly in enhancing bioavailability of poorly soluble drugs, achieving controlled release, and drug targeting. It has resulted in increased efficacy and safety as well as improved patient compliance. Much work has been carried out in areas of nanosuspensions and many products are successfully launched in the market.

References

1. Kim S, Kim JH, Jeon O, Kwon IC, Park K. Engineered polymers for advanced drug delivery. European Journal of Pharmaceutics and Biopharmaceutics. 2009 Mar 1;71(3):420-30.
2. Sahoo SK, Labhasetwar V. Nanotech approaches to drug delivery and imaging. Drug discovery today. 2003 Dec 15;8(24):1112-20.
3. Hughes GA. Nanostructure-mediated drug delivery. Nanomedicine: nanotechnology, biology and medicine. 2005 Mar 1;1(1):22-30.
4. S Thakur R, Agrawal R. Application of nanotechnology in pharmaceutical formulation design and development. Current Drug Therapy. 2015 Apr 1;10(1):20-34.
5. Krishna KB, Prabhakar C. A review on nanosuspensions in drug delivery. Int J Pharma and Bio Sci. 2011;2(1):549-8.
6. Sinha B, Müller RH, Möschwitzer JP. Bottom-up approaches for preparing drug nanocrystals: formulations and factors affecting particle size. International journal of pharmaceutics. 2013 Aug 30;453(1):126-41.
7. Guo Z, Zhang M, Li H, Wang J, Kougoulos E. Effect of ultrasound on anti-solvent crystallization process. Journal of Crystal Growth. 2005 Jan 3;273(3-4):555-63.
8. Xia D, Quan P, Piao H, Piao H, Sun S, Yin Y, Cui F. Preparation of stable nitrendipine nanosuspensions using the precipitation–ultrasonication method for enhancement of dissolution and oral bioavailability. European Journal of Pharmaceutical Sciences. 2010 Jul 11;40(4):325-34..
9. Cocero MJ, Martín Á, Mattea F, Varona S. Encapsulation and co-precipitation processes with supercritical fluids: fundamentals and applications. The Journal of Supercritical Fluids. 2009 Jan 1;47(3):546-55.
10. Kakran M, Sahoo NG, Li L, Judeh Z, Wang Y, Chong K, Loh L. Fabrication of drug nanoparticles by evaporative precipitation of nanosuspension. International Journal of Pharmaceutics. 2010 Jan 4;383(1-2):285-92.
11. Chen MJ, Hui HW, Lee T, Kurtulik P, Surapaneni S, inventors; Celgene Corp, assignee. Nanosuspension of a poorly soluble drug via microfluidization process. United States patent US 9,023,886. 2015 May 5.
12. Muller R, Jacobs C, Kayser O. Disso Cubes: A novel formulation for poorly soluble and poorly bioavailable drugs. Release Drug Delivery Technology, 1st ed.; Rathbone, M., Hadgraft, J., Roberts, M., Eds. 2002 Nov 7:135-49.
13. Keck CM, Müller RH. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. European journal of pharmaceutics and biopharmaceutics. 2006 Jan 1;62(1):3-16.
14. Möschwitzer J, Müller RH. New method for the effective production of ultrafine drug nanocrystals. Journal of nanoscience and nanotechnology. 2006 Sep 1;6(9-10):3145-53.
15. Müller RH. Nanopure technology for the production of drug nanocrystals and polymeric particles. In4th World Meeting of the Italian Association of Professors and Academic Researchers of Pharmaceutics, Pharmaceutical Technology, Biopharmaceutics and Regulatory Affairs. Florence, Italy 2002 Apr.
16. S Thakur R, Agrawal R. Application of nanotechnology in pharmaceutical formulation design and development. Current Drug Therapy. 2015 Apr 1;10(1):20-34.
17. Patel DJ, Patel JK, Pandya VM. Improvement in the dissolution of poorly water soluble drug using media milling technique. Thai Journal of Pharmaceutical Sciences. 2010 Oct 1;34(4).
18. Salazar J, Ghanem A, Müller RH, Möschwitzer JP. Nanocrystals: comparison of the size reduction effectiveness of a novel combinative method with conventional top-down approaches. European Journal of Pharmaceutics and Biopharmaceutics. 2012 May 1;81(1):82-90.
19. Jochmans D. Novel HIV-1 reverse transcriptase inhibitors. Virus research. 2008 Jun 1;134(1-2):171-85..
20. Raju A, Reddy AJ, Satheesh J, Jithan AV. Preparation and characterisation of nevirapine oral nanosuspensions. Indian journal of pharmaceutical sciences. 2014 Jan;76(1):62.
21. Nakarani M, Misra AK, Patel JK, Vaghani SS. Itraconazole nanosuspension for oral delivery: formulation, characterization and in vitro comparison with marketed formulation. Daru: journal of Faculty of Pharmacy, Tehran University of Medical Sciences. 2010;18(2):84.
22. Patel GV, Patel VB, Pathak A, Rajput SJ. Nanosuspension of efavirenz for improved oral bioavailability: formulation optimization, in vitro, in situ and in vivo evaluation. Drug development and industrial pharmacy. 2014 Jan 1;40(1):80-91.
23. Sahu BP, Das MK. Nanoprecipitation with sonication for enhancement of oral bioavailability of furosemide. Acta Pol. Pharm. 2014 Jan 1;71:129-37.
24. Wang Z, Li Z, Zhang D, Miao L, Huang G. Development of etoposide-loaded bovine serum albumin nanosuspensions for parenteral delivery. Drug delivery. 2015 Jan 2;22(1):79-85.
25. Achouri D, Alhanout K, Piccerelle P, Andrieu V. Recent advances in ocular drug delivery. Drug development and industrial pharmacy. 2013 Nov 1;39(11):1599-617.
26. Ahuja M, Verma P, Bhatia M. Preparation and evaluation of chitosan–itraconazole co-precipitated nanosuspension for ocular delivery. Journal of Experimental Nanoscience. 2015 Feb 11;10(3):209-21.
27. Khan MS, Vishakante GD, Bathool A. Development and characterization of pilocarpine loaded Eudragit nanosuspensions for ocular drug delivery. Journal of biomedical nanotechnology. 2013 Jan 1;9(1):124-31.
28. Chiang PC, Alsup JW, Lai Y, Hu Y, Heyde BR, Tung D. Evaluation of aerosol delivery of nanosuspension for pre-clinical pulmonary drug delivery. Nanoscale research letters. 2009 Mar 1;4(3):254..
29. Yang JZ, Young AL, Chiang PC, Thurston A, Pretzer DK. Fluticasone and budesonide nanosuspensions for pulmonary delivery: preparation, characterization, and pharmacokinetic studies. Journal of pharmaceutical sciences. 2008 Nov 1;97(11):4869-78.